1. Home
  2. PURR vs NEO Comparison

PURR vs NEO Comparison

Compare PURR & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hyperliquid Strategies Inc

PURR

Hyperliquid Strategies Inc

N/A

Current Price

$8.74

Market Cap

1.7B

Sector

Health Care

ML Signal

N/A

Logo NeoGenomics Inc.

NEO

NeoGenomics Inc.

N/A

Current Price

$16.90

Market Cap

2.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PURR
NEO
Founded
2025
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Precision Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
2.1B
IPO Year
2025
2008

Fundamental Metrics

Financial Performance
Metric
PURR
NEO
Price
$8.74
$16.90
Analyst Decision
Strong Buy
Buy
Analyst Count
4
11
Target Price
$22.33
★ $23.40
AVG Volume (30 Days)
★ 13.1M
1.9M
Earning Date
11-05-2026
10-28-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
★ 2.54
N/A
Revenue
★ $9,460,000.00
N/A
Revenue This Year
$484.44
$11.12
Revenue Next Year
$31.38
$9.68
P/E Ratio
$3.02
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.01
$7.07
52 Week High
$14.76
$20.15

Technical Indicators

Market Signals
Indicator
PURR
NEO
Relative Strength Index (RSI) 40.50 45.40
Support Level $7.85 $15.73
Resistance Level $9.04 $17.19
Average True Range (ATR) 0.85 0.86
MACD -0.05 -0.01
Stochastic Oscillator 15.11 29.78

Price Performance

Historical Comparison
PURR
NEO

About PURR Hyperliquid Strategies Inc

Hyperliquid Strategies Inc is a digital asset treasury company whose primary focus is to maximize shareholder value through accumulating HYPE, the native token of Hyperliquid, a high-performance blockchain custom-built to house all of finance. HSI aims to provide capital-efficient and productive access to the HYPE token for U.S. and institutional investors, generating compounding shareholder returns that individual holders may not be able to replicate through staking, yield optimization, and active ecosystem engagement. HSI is positioned to become the HYPE-focused digital asset treasury vehicle capitalizing on Hyperliquid's rapid growth and providing exposure to fastest growing revenue pools in digital assets.

About NEO NeoGenomics Inc.

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.

Share on Social Networks: